You searched for Antibody candidate - Page 63 of 69

News and Trends 10 Feb 2022

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

…mixed results in a phase I trial in 2002, and the program was dropped thereafter. There are now several ongoing programs; the most advanced candidate is in a phase I…

February 10, 2022 - 6 minutesmins - By Jonathan Smith

In Depth 9 Aug 2024

The therapeutic potential of circular RNA: Could it soon trump mRNA technology?

…more stable and longer-lasting vaccine candidates than mRNA, and it also means that less of the genetic material is required with circular RNA, which could lead to more vaccines being…

August 9, 2024 - 5 minutesmins - By Willow Shah-Neville

In Depth 11 Mar 2024

Biotech bankruptcies: what to expect in 2024 following a record year?

…in funds that were predicted to run on until 2025 to develop its three cancer drug candidates, was scrapped by MEI because it failed to win stockholder approval. Following layoffs,…

March 11, 2024 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 15 Sep 2017

New British Biotech Enters the Clinic with Opioid Alternative for Chronic Pain

Levicept’s Phase I study will test their new pain relief candidate’s safety and tolerability in healthy individuals and osteoarthritis patients. Levicept, based in Sandwich, UK, focuses on the development of…

September 15, 2017 - 3 minutesmins - By Alex Dale

News and Trends 1 Nov 2017

Belgian Biotech Launches IPO, Readying Itself to Fight Multiple Sclerosis

…and Active Biotech’s multiple sclerosis candidate failed at Phase III, but the news that Roche’s candidate, Ocrevus, was approved by the FDA will have raised the spirits in the field….

November 1, 2017 - 2 minutesmins - By Alex Dale

blindness deafness usher syndrome proqr2 1

News and Trends 13 Feb 2018

ProQR Tackles Blindness Caused by a Rare Genetic Disease

…that has caught the attention of the US-based charity, Foundation Fighting Blindness. The two have come together to develop ProQR’s candidate, QR-421a, which targets blindness caused by the condition. The…

February 13, 2018 - 3 minutesmins - By Alex Dale

News and Trends 5 Sep 2017

UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine

UPDATE (05/09/2017): Innovate UK has granted Themis £3M (€3.3M) to push its Chikungunya Vaccine towards Phase III. Originally Published 06/06/2017 Themis Bioscience will test its vaccine candidate against Chikungunya fever…

September 5, 2017 - 3 minutesmins - By Melanie De Almeida

Startup Scout 13 Sep 2023

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

…be used to confirm a PIM kinase inhibitor clinical candidate for development within nine to 12 months. According to the company, a lead has already been identified, and is currently…

September 13, 2023 - 7 minutesmins - By Willow Shah-Neville

More News! 27 Jun 2019

German Biotech Will Target Parkinsonian Disorders with €12M Series A

Modag has developed a candidate drug targeting the neurodegenerative disease multiple system atrophy, which it plans to take to the clinic with €12M in Series A funds. Multiple system atrophy…

June 27, 2019 - 2 minutesmins - By Helen Albert

News and Trends 4 Mar 2021

Galapagos and Gilead Soldier On After Inflammatory Disease Flops

…the Belgian-Dutch company’s full pipeline. In a bitter twist of biotech fate, however, two of their most promising late-stage candidates, targeting chronic inflammation disorders, hit major snags over the past…

March 4, 2021 - 4 minutesmins - By Victor Kotsev

In Depth 12 Sep 2024

New treatments being developed for schizophrenia

…targets M1 and M4. Moreover, Terran’s preclinical candidate TerXT is also quite similar to KarXT as it contains the same active ingredients – xanomeline and trospium. “[TerXT] is designed to…

September 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 18 Jan 2023

BioInvent receives funding for blood cancer treatments

…antibody BI-1206, in non-Hodgkin’s lymphoma (NHL) and the anti-TNFR2 antibody BI-1808 in cutaneous T-cell lymphoma (CTCL). “We are delighted to conclude this agreement with the widely respected patient organization Leukemia…

January 18, 2023 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

The therapeutic potential of circular RNA: Could it soon trump mRNA technology?

Biotech bankruptcies: what to expect in 2024 following a record year?

New British Biotech Enters the Clinic with Opioid Alternative for Chronic Pain

Belgian Biotech Launches IPO, Readying Itself to Fight Multiple Sclerosis

ProQR Tackles Blindness Caused by a Rare Genetic Disease

UPDATE: Austrian Biotech receives €3.3M boost for its Chikungunya Vaccine

PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders

German Biotech Will Target Parkinsonian Disorders with €12M Series A

Galapagos and Gilead Soldier On After Inflammatory Disease Flops

New treatments being developed for schizophrenia

BioInvent receives funding for blood cancer treatments

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!